Amantadine Hydrochloride
Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Marlex Pharmaceuticals Inc | unknown | 2 | SUPPLYING |
| Strides Pharma Inc. | unknown | 2 | SUPPLYING |
| Coupler LLC | unknown | 1 | SUPPLYING |
| Zhejiang Jutai Pharamceutical Co., Ltd | unknown | 1 | SUPPLYING |
| Upsher-Smith Laboratories, LLC | unknown | 3 | EXITED 2028 |
Shortages, recalls, and registration changes attached to this drug concept.
Amantadine Hydrochloride Tablet — reported in shortage by Upsher-Smith Laboratories, LLC. Therapeutic category: Antiviral, Neurology.
Amantadine Hydrochloride Tablet — reported in shortage by Upsher-Smith Laboratories, LLC. Therapeutic category: Antiviral, Neurology.
CGMP Deviations: Intermittent exposure to temperature excursion during storage. — Recalling firm: Cardinal Health Inc. — FL, GA, SC
Pill